Hyaluronan Versus NaCl 20 Ml Versus Placebo in Knee Osteoarthritis
Osteoarthritis, Knee
About this trial
This is an interventional treatment trial for Osteoarthritis, Knee focused on measuring Hyaluronan, Gonarthrosis, Osteoarthritis,knee, Double-blinded, Placebo controlled, Randomised
Eligibility Criteria
Inclusion Criteria: Patients, men/women age > 60 years with clinical, Radiological and possible arthroscopical verified knee osteoarthritis. Knee pain on the day of examination scoring more than 20 mm on a visual analogue scale (VAS) at baseline. Exclusion Criteria: Age below 60 Unconsciousness Psychosis Demens Ingestion of drugs that may influence the results of the clinical examinations Inflammatory diseases of the joints Rheumatoid arthritis or other inflammatory arthritis as diagnosed by American College of Rheumatology criteria Contraindication to hyalgan treatment Previous intraarticular fracture of a knee joint Infection or skin disease located at the place of injection and invasive procedures done to the knee joint within previous two months inclusive intra-articular injections of steroids. Any other condition that might interfere with the efficacy assessment or completion of the trial.
Sites / Locations
- Copenhagen Trial Unit, H:S Rigshospitalet. dept. 7102